Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1540 studies found for:    Open Studies | "Liver Diseases"
Show Display Options
Rank Status Study
21 Recruiting Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Other: 275mg Oligo Fucoidan + 275mg HS Fucoxanthin;   Other: placebo pills
22 Recruiting Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Dietary Supplement: nutraceutical mixture;   Dietary Supplement: placebo
23 Recruiting Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Conditions: Liver Disease;   Fatty Liver
Intervention:
24 Recruiting Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease
Condition: Nonalcoholic Fatty Liver Disease (NAFLD)
Interventions: Drug: Growth hormone;   Drug: Placebo
25 Recruiting Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease
Condition: Nonalcoholic Fatty Liver Disease (NAFLD)
Interventions: Drug: Perindopril;   Drug: Telmisartan;   Drug: Amlodipine
26 Recruiting Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Device: FibroScan® examination.
27 Recruiting NAFLD Pediatric Database 2
Condition: Liver Disease
Intervention:
28 Recruiting Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver Disease
Conditions: Chronic Liver Disease;   Acute Derangement of Liver Function
Intervention: Other: Acute deterioration of liver function
29 Available Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease
Conditions: Cholestasis;   Liver Diseases
Intervention: Drug: Omegaven
30 Recruiting Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM
Conditions: Liver Disease;   Heart Failure
Intervention:
31 Recruiting Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
Condition: Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions: Drug: Metformin;   Behavioral: Lifestyle modifications;   Device: Fibroscan device (Echosens)
32 Not yet recruiting Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database
Condition: Disease of Liver and Bile Duct
Intervention: Procedure: vibration controlled transient elastography (VCTE)
33 Not yet recruiting MRI to Characterize and Predict CF Liver Disease in PUSH Cohort
Conditions: Cystic Fibrosis Liver Disease;   Pancreatic Insufficiency
Intervention: Procedure: MRI
34 Recruiting Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Conditions: Insulin Resistance;   Nonalcoholic Fatty Liver Disease
Intervention:
35 Recruiting Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases
Conditions: Malnutrition;   Liver Diseases, Alcoholic
Interventions: Device: Gastric tube (Nutricia Flocare® Pur Tube Enlock);   Device: Jejunal tube (Nutricia Flocare® Bengmark®)
36 Recruiting Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
Conditions: Non-Alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis
Interventions: Drug: Saroglitazar magnesium 1 mg;   Drug: Saroglitazar magnesium 2 mg;   Drug: Saroglitazar magnesium 4 mg;   Drug: Placebos
37 Recruiting Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease (NAFLD);   Non-alcoholic Steatohepatitis (NASH)
Interventions: Behavioral: Mediterranean lifestyle;   Behavioral: Mediterranean Diet
38 Not yet recruiting Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Device: CPAP;   Behavioral: LIfestyle
39 Recruiting Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)
Conditions: Non-alcoholic Fatty Liver Disease (NAFLD);   Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: AZ compound;   Other: Placebo
40 Recruiting Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Drug: Runihol;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.